Nucleic acid therapies: Towards cardiac-specific recombinant adeno-associated viruses (rAAVs) of human origin: Directed evolution and characterization of novel AAV variants isolated from human failing hearts in models with human relevance and relevance fo
- Funding ID
81X2500195
- Project number
1326
- Institution
- Universität Heidelberg
- Project leader
- Patrick Most
- Site
- Heidelberg/Mannheim
- Project type
- Innovation Cluster
- Funding
- € 607.835,00
- Begin
- 01.01.2021
- End
- 31.12.2024
- Partner projects